Michele Caraglia

Michele Caraglia's AcademicInfluence.com Rankings

Michele Caraglia

Law

#2717

World Rank

#3374

Historical Rank

Common Law

#136

World Rank

#147

Historical Rank

International Law

#726

World Rank

#889

Historical Rank

law Degrees

Michele Caraglia

Engineering

#6444

World Rank

#7774

Historical Rank

Biomedical Engineering

#571

World Rank

#581

Historical Rank

engineering Degrees

Download Badge

Law
Engineering

Why Is Michele Caraglia Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michele Caraglia's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
Mir-34: A New Weapon Against Cancer? (2014) (440)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence (2012) (211)
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview (2011) (208)
Mitochondria as playmakers of apoptosis, autophagy and senescence. (2020) (206)
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism (2011) (185)
Familial papillary thyroid microcarcinoma: a new clinical entity (1999) (181)
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib. (2010) (180)
Short-Term Diet and Moderate Exercise in Young Overweight Men Modulate Cardiocyte and Hepatocarcinoma Survival by Oxidative Stress (2014) (177)
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease (2013) (171)
Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients (2007) (167)
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: Review article (2004) (162)
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro (2003) (159)
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells (2003) (152)
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. (2007) (150)
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 (2012) (148)
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT (2011) (135)
Anti-Inflammatory Drugs as Anticancer Agents (2020) (133)
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma (2012) (132)
Emerging anti-cancer molecular mechanisms of aminobisphosphonates. (2006) (132)
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells (2005) (131)
MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib. (2015) (128)
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. (2010) (126)
Alpha‐interferon and its effects on signal transduction pathways (2005) (123)
Current approaches and perspectives in the therapy of medullary thyroid carcinoma (2001) (122)
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo (2018) (122)
Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells (1998) (115)
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. (2002) (115)
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer (2001) (111)
Micrornas in prostate cancer: an overview (2017) (106)
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials. (2013) (105)
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma (2014) (104)
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy (2014) (104)
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress (2012) (101)
Mitogen‐activated protein kinases and asthma (2005) (101)
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? (2008) (100)
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. (2011) (98)
Acetylation of proteins as novel target for antitumor therapy: Review article (2004) (97)
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. (2010) (95)
Toll-like receptors and COVID-19: a two-faced story with an exciting ending (2020) (94)
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo (2009) (92)
PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy (2015) (91)
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer (2004) (91)
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients (2013) (89)
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR (2011) (88)
Autophagy induction by trehalose: Molecular mechanisms and therapeutic impacts (2018) (88)
Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell (2013) (88)
Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases (2008) (85)
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. (2012) (85)
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma (2016) (83)
eIF5A isoforms and cancer: two brothers for two functions? (2011) (83)
Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer. (2010) (83)
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. (2011) (83)
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma. (2000) (82)
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study (2011) (81)
Synergistic Antitumor Activity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib and IFN-α in Head and Neck Cancer Cells In vitro and In vivo (2006) (81)
The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate (2004) (80)
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells (2014) (78)
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis (2001) (78)
Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route (2019) (77)
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy (2012) (75)
Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro (2012) (74)
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. (2012) (73)
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials. (2012) (73)
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life (2007) (73)
Interferon-α induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor (1999) (72)
Targeting Autophagy to Overcome Human Diseases (2019) (72)
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study (2010) (72)
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non‐small lung cancer cells (2012) (71)
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. (2003) (70)
Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study (2014) (70)
Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. (2000) (70)
In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor (2008) (69)
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo. (2015) (69)
Dendritic Cell-Mediated Cross-Presentation of Antigens Derived from Colon Carcinoma Cells Exposed to a Highly Cytotoxic Multidrug Regimen with Gemcitabine, Oxaliplatin, 5-Fluorouracil, and Leucovorin, Elicits a Powerful Human Antigen-Specific CTL Response with Antitumor Activity in Vitro1 (2005) (68)
GPR30 is overexpressed in post-puberal testicular germ cell tumors (2011) (68)
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid (2014) (67)
Cetuximab is an active treatment of metastatic and chemorefractory thymoma. (2007) (66)
R115777 (Zarnestra®)/Zoledronic acid (Zometa®) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl‐2 and bad phosphorylation (2007) (66)
EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-α-mediated apoptosis in epidermoid cancer cells (2003) (65)
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients (2016) (63)
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). (2010) (62)
Molecular targets for the treatment of multiple myeloma. (2012) (62)
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours (2005) (62)
Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time? (2013) (59)
C-Raf antagonizes apoptosis induced by IFN-α in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A (2007) (59)
Alpha-interferon and its effects on signalling pathways within cells. (2004) (59)
Protein kinase A as a biological target in cancer therapy. (2009) (59)
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. (2014) (58)
Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours (2019) (58)
Non‐thermal effects of electromagnetic fields at mobile phone frequency on the refolding of an intracellular protein: Myoglobin (2004) (58)
Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. (2005) (57)
Mechanisms of Disease: preclinical reports of antineoplastic synergistic action of bisphosphonates (2006) (57)
Interleukin 18: friend or foe in cancer. (2013) (57)
Nanotechnologies: a strategy to overcome blood-brain barrier. (2012) (56)
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy (2015) (55)
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells (2013) (55)
In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? (2010) (54)
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid (2012) (54)
Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells (2009) (54)
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance (2013) (54)
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells (2015) (53)
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma (2010) (53)
Naturally occurring anti-cancer agents targeting EZH2. (2017) (51)
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse (2016) (51)
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents. (2007) (50)
The novel role of pyrvinium in cancer therapy (2018) (50)
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures (2019) (50)
Carbon nanotubes: Properties, biomedical applications, advantages and risks in patients and occupationally-exposed workers (2015) (49)
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation (2019) (49)
UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism (2017) (49)
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers (2014) (49)
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. (1991) (49)
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. (2009) (49)
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab. (2019) (48)
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). (2001) (48)
Testicular cancer from diagnosis to epigenetic factors (2017) (48)
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma (2014) (48)
Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors (2005) (48)
Zoledronic acid: an unending tale for an antiresorptive agent (2010) (48)
Deregulation of HOX B13 expression in urinary bladder cancer progression. (2013) (48)
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study (2012) (47)
Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth (2012) (46)
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferation. (2014) (46)
The Serine Protease HtrA1 Specifically Interacts and Degrades the Tuberous Sclerosis Complex 2 Protein (2010) (45)
Vascular endothelial growth factor: An important molecular target of curcumin (2019) (45)
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC). (2011) (45)
New treatment approaches in renal cell carcinoma (2009) (45)
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro (2014) (45)
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways (2013) (44)
Apoptotic index or a combination of Bax/Bcl‐2 expression correlate with survival after resection of pancreatic adenocarcinoma (2006) (44)
Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial (2010) (44)
Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells. (1997) (44)
Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization (2011) (43)
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma (2012) (43)
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma (2012) (43)
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. (1999) (43)
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences (2017) (43)
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice. (2010) (43)
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death. (2007) (42)
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells (2012) (42)
Non-coding RNAs as a new dawn in tumor diagnosis. (2017) (41)
MicroRNA‐125a‐5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells (2017) (41)
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer (2005) (40)
Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial (2014) (40)
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age (2008) (39)
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action (2017) (39)
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer (2019) (39)
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. (2012) (39)
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases (2012) (38)
Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells (2018) (38)
α‐interferon potentiates epidermal growth factor receptor‐mediated effects on human epidermoid carcinoma KB cells (1995) (38)
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth. (2016) (38)
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase. (2005) (38)
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. (2002) (38)
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. (2012) (38)
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells (2015) (38)
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer. (2015) (37)
Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients (2015) (37)
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients (2011) (37)
Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation. (2005) (37)
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment (2017) (36)
Emerging pathways as individualized therapeutic target of multiple myeloma (2013) (36)
Interleukin 1β-511T gene (IL1β) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis (1994) (36)
Pegylated liposomal doxorubicin in the management of ovarian cancer (2014) (36)
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state (2008) (35)
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen‐independent prostate cancer cells (2009) (35)
Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (2005) (35)
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. (2014) (35)
Apoptosis induced by interferon‐α and antagonized by EGF is regulated by caspase‐3‐mediated cleavage of gelsolin in human epidermoid cancer cells (2004) (35)
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy. (1999) (34)
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients (2012) (34)
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial (2006) (34)
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: Review article (2004) (34)
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells (2011) (34)
Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice (2005) (34)
First-line systemic therapy for metastatic castration-sensitive prostate cancer: an updated systematic review with novel findings. (2020) (34)
Autophagic cell death: A new frontier in cancer research (2013) (33)
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors (2016) (33)
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17‐dependent TNF‐α activation (2013) (33)
Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection (2016) (33)
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma (2004) (33)
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects. (2009) (33)
Protein kinase A as a biological target in cancer therapy (2009) (32)
Protective Effect of Tyrosol and S-Adenosylmethionine against Ethanol-Induced Oxidative Stress of Hepg2 Cells Involves Sirtuin 1, P53 and Erk1/2 Signaling (2016) (32)
Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40 ml: three years of follow-up. (2001) (32)
Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
Possible antioxidant role of SPA therapy with chlorine–sulphur–bicarbonate mineral water (2009) (31)
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review) (2016) (31)
Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges. (2014) (31)
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. (2009) (31)
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells (2018) (30)
S‐Adenosylmethionine‐mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells (2018) (30)
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer (2005) (30)
Hepatocarcinoma: genetic and epigenetic features. (2018) (30)
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours (2006) (30)
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? (2015) (30)
S-Adenosylmethionine regulates apoptosis and autophagy in MCF-7 breast cancer cells through the modulation of specific microRNAs (2018) (29)
Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy? (2020) (29)
Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies (2017) (29)
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells (2012) (28)
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience (2019) (28)
Targeting Raf-kinase: molecular rationales and translational issues. (2006) (28)
BAG3 Is a Novel Serum Biomarker for Pancreatic Adenocarcinomas (2013) (28)
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series (2010) (28)
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome (2010) (28)
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement. (2019) (28)
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells (2018) (28)
Bisphosphonates and Cancer: What Opportunities from Nanotechnology? (2013) (28)
Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs? (2006) (27)
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis (2020) (27)
Cell communication and signaling: how to turn bad language into positive one (2019) (27)
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients (2010) (27)
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro (2005) (26)
Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine (2018) (26)
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma (2019) (26)
Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells. (2005) (26)
The role of tissue microarray in the era of target-based agents (2011) (26)
Synergistic activity of everolimus and 5‐aza‐2′‐deoxycytidine in medullary thyroid carcinoma cell lines (2017) (26)
Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation (2013) (26)
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer. (2017) (26)
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins (2012) (25)
Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation. (1997) (25)
Molecular dynamics simulation and automated docking of the pro‐apoptotic bax protein and its complex with a peptide designed from the Bax‐binding domain of anti‐apoptotic Ku70 (2006) (25)
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review (2016) (25)
Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells (1998) (25)
Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased raf-1 ubiquitin-dependent degradation (2005) (25)
Exploitation of viral properties for intracellular delivery‡ (2014) (25)
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. (2013) (24)
5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. (1994) (24)
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection. (2013) (24)
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine (2009) (24)
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion (2014) (24)
Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. (2008) (23)
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. (1998) (23)
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours. (2009) (23)
Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice (2000) (23)
Circadian rhythms, adrenergic hormones and trafficking of hematopoietic stem cells (2010) (23)
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia (2020) (23)
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence (2013) (23)
Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. (1995) (22)
Nanotechnologies: New Opportunities for Old Drugs. The Case of Aminobisphosphonates (2011) (22)
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. (2000) (22)
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines (2015) (22)
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade (2020) (22)
miR-29 b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp (2012) (22)
Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress. (2015) (22)
Challenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target therapy. (2009) (22)
Gene interference strategies as a new tool for the treatment of prostate cancer (2015) (22)
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE). (2007) (21)
Structural and functional alterations of cellular components as revealed by electron microscopy (2013) (21)
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer (2020) (21)
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? (2013) (21)
Calcitriol: a better option than vitamin D in denosumab-treated patients with kidney failure? (2013) (21)
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells. (2003) (21)
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. (2011) (21)
Tumour-specific uptake of anti-cancer drugs: the future is here. (2012) (21)
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) (2017) (21)
SCREENING FOR HYPOTHYROIDISM IN OLDER HOSPITALIZED PATIENTS WITH ANEMIA: A NEW INSIGHT INTO AN OLD DISEASE (2010) (21)
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review (2016) (21)
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients (2021) (21)
Anti-Cancer and Radio-Sensitizing Effects of Curcumin in Nasopharyngeal Carcinoma. (2018) (21)
Urotensin‐II receptor is over‐expressed in colon cancer cell lines and in colon carcinoma in humans (2014) (21)
P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia. (2004) (21)
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor (1999) (20)
W7FW14F apomyoglobin amyloid aggregates‐mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac (2009) (20)
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? (2013) (20)
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis) (2014) (20)
Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells (2017) (20)
Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers? (2018) (19)
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules. (2011) (19)
The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines (2015) (19)
Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study. (2015) (19)
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience. (2019) (19)
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. (2002) (19)
Endocrine disruptors and female cancer: Informing the patients (Review). (2015) (19)
The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro‐apoptotic activity of interferon‐α through the inhibition of multiple survival pathways (2007) (19)
Type I interferons: ancient peptides with still under-discovered anti-cancer properties. (2013) (19)
Immunotherapy of colorectal cancer: new perspectives after a long path. (2016) (19)
Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience. (2008) (19)
Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma (2011) (19)
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients. (2017) (18)
Translational and post-translational modifications of proteins as a new mechanism of action of Alpha-Interferon: Review article (2004) (18)
Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells (2013) (18)
Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy. (1994) (18)
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines (2015) (18)
Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI). (2002) (18)
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC (2013) (18)
Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors. (2017) (17)
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer (2020) (17)
Pembrolizumab: the value of PDL1 biomarker in head and neck cancer (2016) (17)
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems (2020) (17)
EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches (2015) (17)
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx (2017) (17)
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells (2019) (17)
Role of perineural invasion as a prognostic factor in laryngeal cancer. (2016) (17)
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report (2008) (17)
Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin (2004) (17)
PYK2 promotes HER2-positive breast cancer invasion (2019) (16)
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells. (2007) (16)
Measurement of Autophagy by Flow Cytometry. (2017) (16)
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up (2019) (16)
AdoMet triggers apoptosis in head and neck squamous cancer by inducing ER stress and potentiates cell sensitivity to cisplatin (2019) (16)
Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel (2008) (16)
EGFR mutational status in penile cancer (2013) (16)
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer. (2015) (16)
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis. (2016) (16)
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response (2016) (16)
Glucocordicoids induce G1 Arrest of Lymphoblastic Cells through Retinoblastoma Protein Rb1 Dephosphorylation in Childhood Acute Lymphoblastic Leukemia In Vivo (2004) (16)
Erlotinib: early clinical development in brain cancer (2014) (16)
Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide. (2021) (16)
Salivary mir-27b expression in oral lichen planus patients: a series of cases and a narrative review of litterature. (2019) (16)
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures (2013) (16)
Long non-coding RNAs in cancer stem cells (2021) (16)
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications (2015) (15)
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors. (2007) (15)
Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells (2007) (15)
Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease) (2005) (15)
Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models (2013) (15)
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs (2013) (15)
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives (2009) (15)
Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer (2010) (15)
Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics. (2011) (15)
Denosumab: the era of targeted therapies in bone metastatic diseases. (2009) (15)
The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer (2021) (15)
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment. (2016) (15)
Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact (2020) (15)
Optimal Management of Prostate Cancer Based on its Natural Clinical History. (2017) (14)
Ipilimumab for the treatment of metastatic prostate cancer (2018) (14)
Potential role of type I interferons in the treatment of pituitary adenomas (2009) (14)
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion (2020) (14)
Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade (2014) (14)
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma. (2016) (14)
Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera? (2011) (14)
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. (2008) (14)
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas (2016) (14)
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides (2021) (14)
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells (2016) (14)
Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways. (2005) (13)
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA. (2020) (13)
Conditions suggesting lymphoma: case 2. Mediastinal liposarcoma in a patient with previous testicular cancer. (2005) (13)
Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: A comparative analysis through time lapse video-microscopy technique (2014) (13)
Keratin 5 expression in squamocellular carcinoma of the head and neck (2014) (13)
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms (2019) (13)
The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity (2016) (13)
Could PD-1/PDL1 immune checkpoints be linked to HLA signature? (2019) (13)
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells. (2017) (13)
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells (2012) (13)
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract (2007) (12)
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. (2013) (12)
miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions (2020) (12)
The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer? (2011) (12)
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma (2017) (12)
Cytosine arabinoside increases the binding of125I-labelled epidermal growth factor and125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb (1993) (12)
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug (2009) (12)
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the β1 integrin profile of cultured human tumor cells (1995) (12)
The role of somatostatin receptors in the medical treatment of acromegaly. (2004) (11)
Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus (2021) (11)
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses. (2016) (11)
Oxidative stress in chronic lymphocytic leukemia: still a matter of debate (2018) (11)
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC (2013) (11)
DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment (2013) (11)
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine (2018) (11)
Identification of a FXIIIA variant in human neuroblastoma cell lines. (2013) (11)
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade (2021) (11)
Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide. (2010) (11)
Impact of curcumin on the regulation of microRNAs in colorectal cancer (2017) (10)
Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells. (1994) (10)
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss. (2006) (10)
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs. (2018) (10)
Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity (2021) (10)
Aryl hydrocarbon receptor, a tumor grade‑associated marker of oral cancer, is directly downregulated by polydatin: A pilot study. (2018) (10)
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells (2019) (10)
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients (2009) (10)
EGF-R small inhibitors and anti-EGF-R antibodies: advantages and limits of a new avenue in anticancer therapy. (2006) (10)
Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research (2020) (10)
Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease? (2021) (10)
Latest developments in targeted therapy for hepatocellular carcinoma (2010) (10)
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation (2017) (9)
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells (2014) (9)
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products (2007) (9)
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat (2017) (9)
Mi-RNA-888-5p Is Involved in S-Adenosylmethionine Antitumor Effects in Laryngeal Squamous Cancer Cells (2020) (9)
p53: From Fundamental Biology to Clinical Applications in Cancer (2022) (9)
Temporal bone meningioma involving the middle ear: A case report. (2015) (9)
New Therapeutic Opportunities from Old Drugs: The Role of Nanotechnology? (2013) (9)
β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism (2020) (9)
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases (2009) (8)
Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma (2012) (8)
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus (2020) (8)
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives. 7 November 2008, Naples, Italy. (2009) (8)
Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities (2021) (8)
A Hydroquinone-Based Derivative Elicits Apoptosis and Autophagy via Activating a ROS-Dependent Unfolded Protein Response in Human Glioblastoma (2019) (8)
Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response (2019) (8)
Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid (2008) (8)
Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak (2021) (7)
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer (2022) (7)
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer (2022) (7)
HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer. (2015) (7)
CheckMate 141 trial: all that glitters is not gold (2019) (7)
Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report (2021) (7)
Erratum to: PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy (2016) (7)
Cytosine arabinoside (Ara‐C) plus alpha‐interferon (αIFN) determine prolonged complete remissions in patients with aggressive non‐Hodgkin's lymphoma partially responsive to first‐line doxorubicin‐containing regimens (1994) (7)
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study (2021) (7)
Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case report (2014) (7)
Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients. (2004) (7)
Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis (2021) (6)
Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance (2018) (6)
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers (2022) (6)
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment (2013) (6)
The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro-apoptotic activity of interferon-α through the inhibition of multiple survival pathways (International Journal of Cancer (2007) 121, (2317-2330)) (2008) (6)
Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortality (2009) (6)
A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial. (2016) (6)
CLINICALLY RELEVANT OF CYTOCHROME P 450 FAMILY ENZYMES FOR DRUG-DRUG INTERACTION IN ANTICANCER THERAPY (2015) (6)
Polydatin Induces Differentiation and Radiation Sensitivity in Human Osteosarcoma Cells and Parallel Secretion through Lipid Metabolite Secretion (2021) (6)
Transient exposure to cytarabine increases peptide growth factor receptor expression and tumorigenicity of melanoma cells. (1997) (6)
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions (2021) (6)
Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study (2008) (6)
ROLE OF ADENOSINE 5' TRIPHOSPHATASE IN LYMPHOKINE ACTIVATED (LAK) KILLING OF HUMAN TUMOR CELLS (1995) (6)
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. (2014) (6)
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis (2018) (6)
S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a (2020) (6)
Breast MALT lymphomas: a clinicopathological and cytogenetic study of 9 cases. (2012) (6)
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice (2021) (6)
Bioactive Peptides in Cancer: Therapeutic Use and Delivery Strategies (2013) (6)
Peptide Functionalization of Silicon for Detection and Classification of Prostatic Cells (2017) (6)
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives (2009) (6)
Structural Characterization of Self-Assembling Hybrid Nanoparticles for Bisphosphonate Delivery in Tumors. (2018) (6)
Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal (2021) (5)
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells. (2015) (5)
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. (2011) (5)
Nanotechnologies in Cancer (2013) (5)
Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)] (2012) (5)
Pegylated liposomal doxorubicin plus temozolamide in the salvage treatment of brain metastases: The update. (2004) (5)
Mediastinal images resembling thymus following 131-I treatment for thyroid cancer. (2005) (5)
Melanoma Adjuvant Treatment: Current Insight and Clinical Features. (2017) (5)
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports (2016) (5)
From single gene analysis to single cell profiling: a new era for precision medicine (2020) (5)
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives. (2009) (5)
Prostate Cancer: Shifting from Morphology to Biology (2013) (5)
Transmembrane ion flux modifiers verapamil and ouabain modulate cytotoxic effects of extracellular ATP on human tumor-cells in-vitro. (1993) (5)
Intraluminal gel ultrasound and eco-color doppler: new tools for the study of colorectal cancer in mice. (2013) (5)
Up‐regulated EGF receptors undergo to rapid internalization and ubiquitin‐dependent degradation in human cancer cells exposed to 8‐Cl‐cAMP (1999) (5)
High-dose recombinant interleukin-2/verapamil combination in advanced cancer. (1996) (5)
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing (2022) (4)
Potential Mechanisms by which Glucocorticoids Induce Breast Carcinogenesis through Nrf2 Inhibition. (2022) (4)
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience (2022) (4)
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer (2005) (4)
Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature—A New Goal for Early Diagnosis and Therapy? (2021) (4)
Covid‐19 laryngectomized patients care, on field experience, and considerations (2021) (4)
Characterization of KRAS Mutational Regression in Oligometastatic Patients (2022) (4)
Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits. (1996) (4)
eIF5A isoforms and cancer: two brothers for two functions? (2011) (4)
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences (2017) (4)
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer (2021) (4)
Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study (2019) (4)
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem (2022) (4)
Concomitant Occurrence of Facial Cutaneous and Parotid Gland Metastases from Rectal Cancer after Preoperative Chemoradiotherapy (2007) (4)
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era (2021) (4)
Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network (2013) (4)
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab (2014) (4)
Renal cancer: Prognostic and predictive biomarkers (2015) (4)
Role of the FAD-dependent polyamine oxidase in the selective formation of N1,N8-bis(γ- glutamyl)spermidine protein cross-links1 (2007) (4)
Concomitant occurrence of a primary renal NHL and of a papillary urothelial ureter cancer. (2007) (4)
Effects of VIP and VIP–DAP on Proliferation and Lipid Peroxidation Metabolism in Human KB Cells (2006) (4)
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry (2022) (4)
γ-Glutamyl 16-diaminopropane derivative of vasoactive intestinal peptide: a potent anti-oxidative agent for human epidermoid cancer cells (2010) (4)
Intravescical Gemcitabine versus Mitomycin for recurrent superficial bladder tumours (stages pTa and pT1): A randomized prospective study (2008) (3)
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients (2008) (3)
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians (2017) (3)
Atypical cutaneous lymphoid hyperplasia induced by chemotherapy in a patient with advanced colon carcinoma. (2007) (3)
Phorbol 12-myristate 13-acetate (pma) induces neuroendocrine-like differentiation and reverses Doxorubicin-resistance of human colon-carcinoma cells in-vitro. (1994) (3)
Editorial: target therapy in brain tumours and metastases. (2012) (3)
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) (2008) (3)
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol (2021) (3)
Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications (1998) (3)
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) (2021) (3)
Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution (2008) (3)
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy. (2008) (3)
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum (2022) (3)
Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study (2019) (3)
COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm (2021) (3)
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy (2018) (3)
[Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. (2011) (3)
Role of the FAD-dependent polyamine oxidase in the selective formation of N(1),N(8)-bis(gamma-glutamyl)spermidine protein cross-links(1). (2007) (3)
alpha-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. (1996) (2)
A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology. (2007) (2)
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo (2018) (2)
Correlation of survival of NSCLC patients given nivolumab with treatment related-eosinophilia, autoimmunity and previous bevacizumab containing regimens. (2018) (2)
Target-based agents in neo-adjuvant treatment of liver metastases from colo-rectal cancer: Secret weapons in anticancer war? (2009) (2)
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients (2022) (2)
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR (2022) (2)
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study. (2020) (2)
From Protein Synthesis to Molecular Biology: The Appealing Tale of eIF-5A (2014) (2)
Mitoxantrone, Etoposide and bleomycin (meb) chemotherapy in non-hodgkins-lymphoma patients non-elegible for standard cyclophosphamide, Doxorubicin, vincristine and prednisone (chop) combination. (1995) (2)
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use (2022) (2)
Differential transcriptional response to cisplatinum in BRCA1-defectiveversusBRCA1-reconstituted breast cancer cells by microarrays. (2009) (2)
Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy. (2008) (2)
Phase II studies of anticancer chemotherapy: indirect evidence of poor quality. (2006) (2)
Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma (2010) (2)
Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer (2009) (2)
Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point? (2022) (2)
miRNA as Prognostic and Therapeutic Targets in Tumor of Male Urogenital Tract (2016) (2)
Small tumor of the medial breast presenting with a contralateral lymph node involvement detected on positron emission tomography scan. (2007) (2)
Nanotechnologies to use zoledronic acid as a potent antitumoral agent (2011) (2)
Comment on: EGFR mutational status in Brazilian patients with penile carcinoma (2013) (2)
Neuroendocrine Differentiation in Prostate Cancer (2013) (1)
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion (2014) (1)
Vinflunine and bladder cancer: present and future indications (2017) (1)
Bevacizumab-Induced Tumor Vasculature Normalization and Sequential Chemotherapy in Colorectal Cancer: An Interesting and Still Open Question (2021) (1)
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results (2021) (1)
Tailored combined treatment with radiofrequency ablation plus octreotide in advanced hepatocellular carcinoma (2007) (1)
Nanotechnological and biotechnological strategies for drug delivery. (2012) (1)
Editorial [Hot Topic: Nanotechnological and Biotechnological Strategies for Drug Delivery (Guest Editors: Massimiliano Galdiero and Michele Caraglia)] (2012) (1)
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review (2022) (1)
Modeling Lung Carcinoids with Zebrafish Tumor Xenograft (2022) (1)
166 Prostate cancer associated fibroblasts exhibit a distinctive gene expression signature as compared against normal and BPH-derived prostate fibroblasts (2015) (1)
Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL). (1996) (1)
Interleukin 1 ß-511 T gene ( IL 1 ß ) polymorphism is correlated with gastric cancer in the Caucasian population : Results from a meta-analysis (1)
S-Adenosylmethionine regulates apoptosis and autophagy in MCF-7 breast cancer cells through the modulation of specific microRNAs (2018) (1)
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress (2012) (1)
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug (2017) (1)
The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration. (2017) (1)
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer (2022) (1)
Comparative Study of NGS Platform Ion Torrent Personal Genome Machine and Therascreen Rotor-Gene Q for the Detection of Somatic Variants in Cancer (2020) (1)
Highlights of the Pananemia National meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia (2009) (1)
FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land. (2017) (1)
Correction to: Cell communication and signaling: how to turn bad language into positive one (2019) (1)
Uratensin-II receptor: A new diagnostic marker and therapeutic target in human prostate adenocarinoma (2007) (1)
Chronic Pain and Oxidative Stress in Knee Osteoarthritis: Role of Sulphurous Mud-Balneotherapy (2015) (1)
Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation (2022) (1)
Tuberculous Lymphadenitis in Southern Italy: Clinical Aspects and Treatment Perspectives (2014) (1)
Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen resistant prostate cancer cell line (PC3) (2006) (1)
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer (2023) (1)
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion. (1994) (1)
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection (2022) (1)
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials. (2022) (1)
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival (2023) (1)
Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation (2013) (1)
785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY (2009) (1)
Structural organization of the human eukaryotic initiation factor 5A precursor and its site-directed variant Lys50 → Arg (2005) (1)
461P Real-time PCR-based assessment of RAS/BRAF mutations in the plasma of metastatic colorectal cancer (mCRC) patients: A single institution experience (2020) (1)
Phase I clinical study on docetaxel/zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients (2007) (1)
New strategies based on Zoledronic Acid/TIPIFARNIB combination in the therapy of prostate cancer (2006) (1)
1245 Zoledronic acid and Taxotere (ZANTE) metronomic and sequential administration in patients with hormone refractory prostate cancer (HRPC) – final results of phase I study (2009) (1)
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment (2017) (1)
Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives (2022) (1)
Protein Kinase A Detection in Human Urine Samples (2021) (1)
Erratum: Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer (British Journal of Cancer (2004) 92 (24-29) DOI:10.1038/sj.bjc.6602579) (2005) (1)
13PTumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy (2016) (1)
Cell communication and signaling: how to turn bad language into positive one (2019) (1)
A liver angioma colonized by colon cancer cells in a patient with two primitive localizations by colon adenocarcinoma: biologic, diagnostic and therapeutic implications. (2005) (1)
CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia. (1993) (1)
Future directions and management of liquid biopsy in non-small cell lung cancer (2020) (1)
Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell (2013) (1)
Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study (2008) (1)
On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer (2020) (1)
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS (2010) (1)
Immunohistochemical Examination of E-Cadherin in the Head and Neck Squamocellular Carcinomas (2014) (1)
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. (2014) (1)
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells (2018) (1)
Therapeutic nanoproducts: from biology to innovative technology (2019) (1)
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer: Rapid Turnover and Use of Folates Alter its Study—Letter (2020) (0)
Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE (2008) (0)
Sign The Deg (2010) (0)
Editorial Nanotechnologies in Cancer (2015) (0)
P.08.6 UROTENSIN-II RECEPTOR: A NEW MARKER FOR THE DIFFERENTIATION AND THE TARGET IN COLON CANCER? (2012) (0)
The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates α-thrombin activity: potential clinical implications (2008) (0)
MEK-1 inhibitor PDO8059 potentiates apoptosis and growth inhibition induced by intereferon alpha (IFN alpha) in human epidermoid cancer cells. (2000) (0)
LOCAL ORGANIZING COMMITEE (2014) (0)
Combined administration of darbepoetin and zoledronic acid in the treatment of refractory multiple myeloma (MM) (2006) (0)
PGI6 ECONOMIC EVALUATION OF RABEPRAZOLE VS. OMEPRAZOLE IN THE CURATIVE TREATMENT OF REFLUX OESOPHAGITIS (2004) (0)
Zoledronic acid induces anti-cancer effects on prostate cancer cells through the modulation of the angiogenesis associated CYR61 and the androgen-differentiation associated NDRG-1 genes (2007) (0)
Erratum to: The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines (2016) (0)
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer (2019) (0)
Atypical amplification of chromosome (2015) (0)
Zoledronic Acid Increases the Expression of Ndrg1 Gene In Human Androgen-independent Prostate Cancer Pc3 Cells (2010) (0)
828 Antitumor activity of nanovectors encapsulating zoledronic acid (ZOL) in 3D prostate carcinoma spheroids (2013) (0)
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells (2016) (0)
Phase I clinical trial of high dose recombinant interleukin-2/veparimil combination in advancer cancer. (1996) (0)
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review (2023) (0)
CTL Response with Antitumor Activity in Elicits a Powerful Human Antigen-Specific Oxaliplatin, 5-Fluorouracil, and Leucovorin, Multidrug Regimen with Gemcitabine, Cells Exposed to a Highly Cytotoxic of Antigens Derived from Colon Carcinoma Dendritic Cell-Mediated Cross-Presentation (2005) (0)
Liposomes containing zoledronic acid: A new opportunity against cancer (2010) (0)
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat (2016) (0)
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins (2012) (0)
6140 POSTER Cetuximab-mediated Immune-enhancing Effects in Vitro and in Metastatic Colorectal Cancer (mCRC) Patients (2011) (0)
CYR61 down-modulation sensitizes prostate cancer cells to zoledronic acid and docetaxel: A new anti-cancer strategy (2008) (0)
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions (2014) (0)
Comparative proteomic analysis of head and neck cancer cells treated with histone deacetylase inhibitor SAHA and epidermal growth factor receptor inhibitor Gefitinib by two-dimensional gel electrophoresis and mass spectrometry (2005) (0)
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives (2023) (0)
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity (2005) (0)
Pentose phosphate pathway inhibition induce Endoplasmic Reticulum stress and autophagy (2017) (0)
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor (2004) (0)
Up-regulation of EGF-receptor induced by alpha-interferon in human A431 cells. (1990) (0)
PPAR γ activation potentiates interferon-beta activity in human pancreas adenocarcinoma through post-translational regulation of P21 and P27 (2010) (0)
The farnesyl-transferase r115777 and the aminobisphosphonate zoledronic acid synergize on the apoptosis and on the growth inhibition of human cancer cells (2009) (0)
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas (2016) (0)
P2.05-057 Baseline Inflammatory and Immunological Profile Predict the Survival of NSCLC Patients Undergone Palliative Radiotherapy: Topic: Toxicities (2017) (0)
Synergistic AntitumorActivity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib and IFN-A in Head and Neck Cancer Cells In vitro and In vivo (2006) (0)
PYK2 promotes HER2-positive breast cancer invasion (2019) (0)
Determination of miRNAs from Cancer Stem Cells Using a Low Density Array Platform. (2018) (0)
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures (2019) (0)
Urotensin-II Receptor Regulates Cell Mobility/Invasion and Determines Prognosis of Bladder Cancer (2013) (0)
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine (2023) (0)
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer (2020) (0)
P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab: Topic: Clinical Trials (2017) (0)
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer (2022) (0)
Mechanism of alpha-interferon induced upregulation of EGF receptors in human cancer cell lines (1990) (0)
A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias (2022) (0)
Efficacy in randomised trials: the time matters. (2022) (0)
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis (2022) (0)
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy (2008) (0)
Atypical amplification of chromosome region 22q12 in melanoma: A case report. (2015) (0)
Experimental and Clinical Immunology (1996) (0)
The farnesyl transferase inhibitor (FTI) R115777 (Zarnestra®) inhibits the survival pathways activated by alpha Interferon in human epidermoid cancer cells (2005) (0)
Related articles (2013) (0)
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy (2018) (0)
Self-assembling nanoparticles containing zoledronic acid : A new scenario for the treatment of glioblastoma (2014) (0)
Abstract PO-052: A pilot study of miRNA expression profile in surgically resected pancreatic ductal adenocarcinoma: Initial report from a bi-institutional cohort (2021) (0)
Phorbol-12-myristate-13-acetate (PMA) induces resistance of human melanoma cells to NK and LAK-mediated cytotoxicity. (1992) (0)
Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours (2007) (0)
5-aza-2-deoxycytidine affects growth and surface cell phenotype of colon carcinoma CaCo-2 cells (1990) (0)
What is the purpose of launching the Translational Medicine Reports journal (2017) (0)
Basal Cell Carcinoma: Molecular and Pathological Features (2014) (0)
Review for "HSP90 identified by a proteomic approach as druggable target to reverse platinum‐resistance in ovarian cancer" (2020) (0)
Author response: miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions (2020) (0)
Target therapy of bone metastases and tumours. (2009) (0)
Cutaneous Squamous Cell Carcinoma: Focus on Biochemical and Molecular Characteristics (2014) (0)
787: Transferrin-conjugated self assembled nanoparticles incorporating ZOL as a tool for the targeting of glioblastoma (2014) (0)
Acetylation of proteins as potential novel target for antitumor therapy (2003) (0)
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients (2016) (0)
1320 ZOLEDRONIC ACID (ZOL) ENCAPSULATED INTO LIPOSOMES AND NANOPARTICLES: ENHANCED ANTITUMOR ACTIVITY IN 3D- PROSTATE CARCINOMA SPHEROIDS (2013) (0)
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation (2019) (0)
Acknowledgement of reviewers 2012 (2013) (0)
Polydatin (3,4’,5-trihydroxystilbene-3-β-d-glucoside) is a new inhibitor of glucose-6-phosphate dehydrogenase affecting cancer metabolism and producing a strong cytotoxic and antimetastatic effect (2016) (0)
Abstract 5231: Zoledronic acid encapsulated into liposomes and nanoparticles: Enhanced antitumor activity in 3D-prostate carcinoma spheroids (2012) (0)
List of Referees, 2009 (2010) (0)
Genotype-basedtherapeutic approachforcolorectal cancer:stateoftheartand futureperspectives (2009) (0)
From single gene analysis to single cell profiling: a new era for precision medicine (2020) (0)
Effects of total antigens of Dicrocoelium dendriticum on human epatocarcinoma cells (2015) (0)
Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study (2008) (0)
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. (2006) (0)
Lanreotide (LAN) increases the sensitivity of human medullary carcinoma TT cells to Interleukin-2 activated lymphocytes (2005) (0)
Gene signatures predictive of response to radiotherapy in prostate cancer: a new step towards precision medicine (2017) (0)
Correction to: Cell communication and signaling: how to turn bad language into positive one (2019) (0)
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis) (2013) (0)
Prospective observational study (ZORES Study) on analysis of genetic mutations and enzymatic activity of Farnesyl Pyrophosphate Synthetase (FPPS) as predictive factor of resistance to amino-bisphosphonates (N-BP) in patients with bone metastases from solid tumors (2008) (0)
The Tumor Dynamism Is the Dark Matter of the NGS Galaxy: How to Understand It? (2021) (0)
Original Article Identification of a FXIIIA variant in human neuroblastoma cell lines (2013) (0)
Highlights of the Pananemia National Meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia. Sorrento, Italy, 19-20 December 2008. (2009) (0)
Self-assembling nanoparticles containing zoledronic acid: a new challenge for the treatment of brain tumors (2013) (0)
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part II) (2008) (0)
A structured algorithm to assess the response to biological therapy in medullary thyroid carcinoma (1999) (0)
Alberto Abbruzzese (1952–2011) Scientist who studied from amino acids to nanoparticles in anti-cancer therapy (2012) (0)
A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone in docetaxel-pretreated men with metastatic castration resistant prostate cancer (mCRPC): The CABACARE trial. (2019) (0)
Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)] (2009) (0)
The Art of Counseling in the Treatment of Head and Neck Cancer: Exploratory Investigation among Perceptions of Health Professionals in Southern Italy (2021) (0)
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus. (2022) (0)
11PD Tapping CD4 T cells for cancer immunotherapy (2016) (0)
Abstract 2609: Tissue transglutaminase (TG2) promotes resistance to HDAC inhibitor (HDI) vorinostat in cancer cells (2011) (0)
Intrinsic Resistance To the Antiproliferative Effects of Azd6244 a Selective Mek1/2 Inhibitor Is Associated With Concomitant K-ras and Pi3kca Gene Mutations in Colorectal Cancer Cells (2010) (0)
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells (2022) (0)
Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerations. (2021) (0)
Molecular Cancer esearch aling and Regulation Serine Protease HtrA 1 Specifically Interacts and R rades the Tuberous Sclerosis Complex 2 Protein (2010) (0)
183P Prognostic value of high mesenchymal-epithelial transition factor gene (MET) expression in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor negative (HER2-) early breast cancer (2020) (0)
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics (2023) (0)
Modulation of FPPS's activity following NBPs therapy: clinical implications (2010) (0)
Abstract 891: The chemokine receptor CXCR7 transduces its signal through mTOR: the role of everolimus (2012) (0)
274 POSTER Effect of IFN-α on gene expression: cDNA microarray analsis in human epidermoid cancer cells (2006) (0)
OBITUARY (1958) (0)
Correlation of HLA-B*35 and DRB1*11 alleles with a high risk of interstitial aseptic pneumonitis in cancer patients receiving PD-1/PDL1 immune-checkpoint blockade. (2020) (0)
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michele Caraglia?

Michele Caraglia is affiliated with the following schools:

University of Duisburg-Essen
Università degli Studi della Campania Luigi Vanvitelli
University of Oxford
University of Siena
Temple University
Università Cattolica del Sacro Cuore

Michele Caraglia's Academic­Influence.com Rankings

Why Is Michele Caraglia Influential?

Michele Caraglia's Published Works

Published Works

What Schools Are Affiliated With Michele Caraglia?

Michele Caraglia's AcademicInfluence.com Rankings